100 related articles for article (PubMed ID: 20214572)
1. High content screening of CXCR2-dependent signalling pathways.
Wolff M; Kredel S; Haasen D; Wiedenmann J; Nienhaus GU; Kistler B; Oswald F; Heilker R
Comb Chem High Throughput Screen; 2010 Jan; 13(1):3-15. PubMed ID: 20214572
[TBL] [Abstract][Full Text] [Related]
2. CXCR2 inverse agonism detected by arrestin redistribution.
Kredel S; Wolff M; Wiedenmann J; Moepps B; Nienhaus GU; Gierschik P; Kistler B; Heilker R
J Biomol Screen; 2009 Oct; 14(9):1076-91. PubMed ID: 19773589
[TBL] [Abstract][Full Text] [Related]
3. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
4. Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.
Rossant CJ; Carroll D; Huang L; Elvin J; Neal F; Walker E; Benschop JJ; Kim EE; Barry ST; Vaughan TJ
MAbs; 2014; 6(6):1425-38. PubMed ID: 25484064
[TBL] [Abstract][Full Text] [Related]
5. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
[TBL] [Abstract][Full Text] [Related]
6. CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer.
Korbecki J; Kupnicka P; Chlubek M; Gorący J; Gutowska I; Baranowska-Bosiacka I
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216283
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
Katancik JA; Sharma A; de Nardin E
Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
[TBL] [Abstract][Full Text] [Related]
8. Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation.
Richardson RM; Marjoram RJ; Barak LS; Snyderman R
J Immunol; 2003 Mar; 170(6):2904-11. PubMed ID: 12626541
[TBL] [Abstract][Full Text] [Related]
9. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.
Zaslaver A; Feniger-Barish R; Ben-Baruch A
J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710
[TBL] [Abstract][Full Text] [Related]
10. Redirecting migration of T cells to chemokine secreted from tumors by genetic modification with CXCR2.
Kershaw MH; Wang G; Westwood JA; Pachynski RK; Tiffany HL; Marincola FM; Wang E; Young HA; Murphy PM; Hwu P
Hum Gene Ther; 2002 Nov; 13(16):1971-80. PubMed ID: 12427307
[TBL] [Abstract][Full Text] [Related]
11. A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome: regulatory effects of pro-inflammatory cytokines.
Lisi S; Sisto M; Lofrumento DD; D'Amore M; De Lucro R; Ribatti D
Histochem Cell Biol; 2013 Feb; 139(2):371-9. PubMed ID: 23052840
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer.
Lee CH; Syu SH; Liu KJ; Chu PY; Yang WC; Lin P; Shieh WY
Oncotarget; 2015 Nov; 6(36):38866-80. PubMed ID: 26462152
[TBL] [Abstract][Full Text] [Related]
13. Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization.
Boon K; Vanalken N; Szpakowska M; Chevigné A; Schols D; Van Loy T
Cell Commun Signal; 2024 Jan; 22(1):43. PubMed ID: 38233929
[TBL] [Abstract][Full Text] [Related]
14. Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor.
Mueller SG; White JR; Schraw WP; Lam V; Richmond A
J Biol Chem; 1997 Mar; 272(13):8207-14. PubMed ID: 9079638
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profiling of chemokine receptor-directed compounds using high-content screening.
Haasen D; Merk S; Seither P; Martyres D; Hobbie S; Heilker R
J Biomol Screen; 2008 Jan; 13(1):40-53. PubMed ID: 18227225
[TBL] [Abstract][Full Text] [Related]
16. Intracellular trafficking of human CXCR1 and CXCR2: regulation by receptor domains and actin-related kinases.
Matityahu E; Feniger-Barish R; Meshel T; Zaslaver A; Ben-Baruch A
Eur J Immunol; 2002 Dec; 32(12):3525-35. PubMed ID: 12442335
[TBL] [Abstract][Full Text] [Related]
17. New insights into ADAMs regulation of the GRO-α/CXCR2 system: focus on Sjögren's syndrome.
Sisto M; Lisi S
Int Rev Immunol; 2015; 34(6):486-99. PubMed ID: 25386842
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus diminishes the expression of GRO-α (CXCL-1) /CXCR2 axis in human keratinocytes and cutaneous squamous cell carcinoma cells.
Schaper-Gerhardt K; Hansel A; Walter A; Grimmelmann I; Gutzmer R
J Dermatol Sci; 2021 Oct; 104(1):30-38. PubMed ID: 34479772
[TBL] [Abstract][Full Text] [Related]
19. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.
Wang B; Hendricks DT; Wamunyokoli F; Parker MI
Cancer Res; 2006 Mar; 66(6):3071-7. PubMed ID: 16540656
[TBL] [Abstract][Full Text] [Related]
20. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
